# The Role of Somatostatin in the Hemodynamics of the Hepatic Circulation in Patients Undergoing Liver Resection

> **NCT04010669** · PHASE3 · UNKNOWN · sponsor: **Laikο General Hospital, Athens** · enrollment: 40 (estimated)

## Conditions studied

- Portal Hypertension

## Interventions

- **DRUG:** Somatostatin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04010669
- **Lead sponsor:** Laikο General Hospital, Athens
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-08-01
- **Primary completion:** 2020-03-31
- **Final completion:** 2020-07-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2019-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04010669

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04010669, "The Role of Somatostatin in the Hemodynamics of the Hepatic Circulation in Patients Undergoing Liver Resection". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT04010669. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*